ARQT icon

Arcutis Biotherapeutics

167 hedge funds and large institutions have $1.24B invested in Arcutis Biotherapeutics in 2024 Q1 according to their latest regulatory filings, with 58 funds opening new positions, 52 increasing their positions, 40 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
167
Holders Change
+34
Holders Change %
+25.56%
% of All Funds
2.42%
Holding in Top 10
6
Holding in Top 10 Change
+5
Holding in Top 10 Change %
+500%
% of All Funds
0.09%
New
58
Increased
52
Reduced
40
Closed
23
Calls
$6.39M
Puts
$11.1M
Net Calls
-$4.68M
Net Calls Change
-$4.68M
Name Holding Trade Value Shares
Change
Shares
Change %
GCM
176
Ghisallo Capital Management
Massachusetts
-$323K -100,000 Closed
Marshall Wace
177
Marshall Wace
United Kingdom
-$307K -95,011 Closed
SI
178
Symmetry Investments
Jersey
-$178K -55,000 Closed
BHCM
179
Brevan Howard Capital Management
Jersey
-$166K -51,442 Closed
CC
180
Centiva Capital
New York
-$67.8K -20,984 Closed
Wealth Enhancement Advisory Services
181
Wealth Enhancement Advisory Services
Minnesota
-$64.6K -20,000 Closed
WSTAM
182
Wilbanks Smith & Thomas Asset Management
Virginia
-$64.6K -20,000 Closed
YIH
183
Y-Intercept (HK)
Hong Kong
-$51K -15,804 Closed
Walleye Trading
184
Walleye Trading
New York
-$39.6K -12,250 Closed
CF
185
Cantor Fitzgerald
New York
-$32.7K -10,114 Closed
CIA
186
Cape Investment Advisory
Georgia
-$25.9K -8,004 Closed
VL
187
Vima LLC
Michigan
-$9.69K -3,000 Closed
LF
188
Lee Financial
Texas
-$9.23K -2,856 Closed
HI
189
Harbour Investments
Wisconsin
-$97 -30 Closed